-
Citigroup Notifies That Stabilization Measures Have Been Undertaken in Calliditas Therapeutics' ADSs Traded on The Nasdaq Global Select Market
-
Calliditas Therapeutics Prices its Initial Public Offering on The Nasdaq Global Select Market in the United States
-
Calliditas Therapeutics Launches US IPO Roadshow and Targets a Capital Raise of MUSD 75

